AIM ImmunoTechNYSE American: AIM

OCALA, Fla., July 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the next CEO Corner segment has been published on the Company's website. For the CEO Corner segment, AIM Chief Executive Officer Thomas Equels provided an update on the Phase 1b/2 “DURIPANC” study of Ampligen and AstraZeneca's Imfinzi as a combination therapy for late-stage pancreatic cancer. The Company also provided a business update, including that as a result of recent financings, AIM recently had stockholders' equity of $6.9 million.

Phoenix Copper Ltd (AIM:PXC, OTCQX:PXCLF) highlighted to investors that US$110 million of corporate copper bonds have been admitted to trading on the official list of the International Stock Exchange (TISE). The AIM-quoted US-focused company said the bonds have a maturity date of 27 December 2033 and will remain listed on TISE until the earlier of maturity or repayment.

Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) had a 'buy' rating from Stifel reiterated after the company secured a $16.5 million upfront payment from global mining equipment giant Caterpillar for its Guardian driver monitoring product. Alongside the contract, the AIM- and OTC-listed company also provided a trading update as the end of its current financial year approaches, where it said revenue and cash are set to finish "at or ahead of market expectations".

OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K.

CHICAGO--(BUSINESS WIRE)-- #CRM--Advyzon Investment Management (AIM), a turnkey asset management program (TAMP) under the umbrella of comprehensive technology platform Advyzon, announced today the hiring of Scott Smith as Chief Revenue Officer (CRO). An accomplished executive in the financial services industry – having previously worked at Goldman Sachs, BNY Mellon | Pershing, Envestnet, Fidelity, Schwab Advisor Services, and TD Ameritrade Institutional – Smith brings his 20+ years of industry experie.

Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, June 5th at 12:00 PM ET Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, June 5th at 12:00 PM ET

OCALA, Fla., May 31, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,640,958 shares of common stock in a registered direct offering at a purchase price of $0.363 per share. In a concurrent private placement, the Company also agreed to issue unregistered Class A warrants to purchase up to an aggregate of 5,640,958 shares of common stock and, unregistered Class B warrants to purchase up to an aggregate of 5,640,958 shares of common stock. The Class A and Class B warrants will each have an exercise price of $0.363, will be exercisable six months from the date of issuance and, in the case of the Class A warrants, will expire on the eighteen-month anniversary from the initial exercise date, and in the case of the Class B warrants, will expire on the five-year anniversary from the initial exercise date.

OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that AIM Chief Executive Officer Thomas K. Equels will participate in two upcoming investor conferences.

AFC Energy PLC has secured a deal to provide its hydrogen-powered S Series fuel cell modules to Niftylift, a major supplier of mobile elevated work platforms in Europe. The collaboration involves selling the fuel cell modules tailored for Niftylift's hydrogen-electric ‘H2E' range of powered access MEWPs.